Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 16NETWORK 2UNKNOWN 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Injections 53Cisplatin 47Paclitaxel 46Carboplatin 41Gemcitabine 37Docetaxel 36Capecitabine 36pembrolizumab 35Drug Therapy 34anlotinib 25icotinib 23Fluorouracil 23Bevacizumab 23Cyclophosphamide 22Oxaliplatin 19fludarabine 18Pemetrexed 17Irinotecan 16Leucovorin 15Temozolomide 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Nivolumab 13Trastuzumab 11Rituximab 11Etoposide 11tesetaxel 10SHR-1701 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Methods × Clear all
NCT01219192 2010-10-28

Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure

Protgen Ltd

Phase 1 Unknown
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡